Navigation Links
Neurimmune Therapeutics Announces Advancement of Alzheimers Program into Preclinical Development
Date:8/18/2009

Zurich, Switzerland, August 18, 2009 / b3c newswire / -Neurimmune Therapeutics AG today announced that, following the successful completion of key research milestones, its lead human therapeutic antibody for Alzheimers disease has advanced into preclinical development, triggering milestone payments of an undisclosed amount from Biogen Idec (NASDAQ: BIIB). Neurimmune partnered with Biogen Idec for the worldwide development and commercialization of novel, fully human antibodies for the treatment of Alzheimers disease in November 2007. The alliance focuses on the development of antibodies that bind to amyloid beta (Abeta), a pathogenic molecule thought to cause neurodegeneration and loss of cognitive function in Alzheimers patients.

Neurimmunes unique Reverse Translational Medicine (RTM) technology platform combined with in-depth expertise in neuroscience played a critical role in moving the program forward. The fact that we could reach all preclinical milestones in such a short period of time shows that our RTM technology can significantly accelerate the transition from discovery to development of human monoclonal antibodies, said Jan Grimm, Chief Scientific Officer of Neurimmune Therapeutics.

The rapid advancement into preclinical development demonstrates the progress and productivity of our collaboration with Biogen Idec we are very happy to work with a partner that has such extensive and valuable experience in the development of biopharmaceuticals. The significant milestone payments also provide Neurimmune with additional financial stability to support the sustainable future development of our company, said Michael Salzmann, COO and General Manager of Neurimmune Therapeutics.

Biogen Idec is globally recognized as a leader in the development of innovative therapies for neurologic diseases, and this program is an important entry into Alzheimers disease for us, said Kenneth Rhodes, PhD, Vice President, Discovery
'/>"/>
b3c newswire

Page: 1 2 3

Related biology news :

1. Amarna Therapeutics B.V. and TNO announce SVac research and development partnership
2. Continuous glucose monitoring technology -- special issue of Diabetes Technology and Therapeutics
3. NIH announces new program to develop therapeutics for rare and neglected diseases
4. Ocera Therapeutics licenses novel treatment for acute hepatic encephalopathy from UCLB
5. Tufts University professor receives IADR Pharmacology/Therapeutics/Toxicology Award
6. Acorda Therapeutics submits new drug application for Fampridine-SR in multiple sclerosis
7. A novel target for therapeutics against Staph infection
8. Bayhill Therapeutics and the Juvenile Diabetes Research Foundation announce research collaboration
9. Growing fuel and medicine: Advancing biofuels and plant-produced therapeutics
10. Sirtris review of sirtuin therapeutics for diseases of aging in Nature Reviews Drug Discovery
11. Media invitation: 20th EORTC-NCI-ACR Symposium on Molecular Targets and Cancer Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... that could overcome a major cost barrier to ... could replace expensive and environmentally harmful fossil fuels. ... that performs almost as well as cost-prohibitive platinum ... to split water molecules into hydrogen and oxygen. ... than less-expensive catalysts investigated to-date. , "Hydrogen has ...
(Date:7/14/2014)... to reliably and safely make in the laboratory all of ... key step closer to reality. , Writing today in the ... of Wisconsin-Madison stem cell researcher Igor Slukvin reports the discovery ... and turning them into both red and the array of ... is important because it identifies how nature itself makes blood ...
(Date:7/13/2014)... in women suggests that experiencing one or more stressful ... can slow the body,s metabolism, potentially contributing to weight ... day,s stressors before giving them a meal consisting of ... then measured their metabolic rate how long it ... and took measures of blood sugar, triglycerides, insulin and ...
Breaking Biology News(10 mins):Rutgers chemists develop technology to produce clean-burning hydrogen fuel 2Wisconsin scientists find genetic recipe to turn stem cells to blood 2Wisconsin scientists find genetic recipe to turn stem cells to blood 3Weighty issue: Stress and high-fat meals combine to slow metabolism in women 2Weighty issue: Stress and high-fat meals combine to slow metabolism in women 3Weighty issue: Stress and high-fat meals combine to slow metabolism in women 4
... Peering deep within the cells of fruit flies, developmental ... University in Philadelphia may have discovered a new way ... If they're right, and the same processes are at ... eventually have implications for improving the understanding of a ...
... change will have major effects on coral reefs ?and has ... from the ARC Centre of Excellence for Coral Reef Studies ... engineering model to predict how much damage a reef is ... sea. , In a paper in the international ...
... unique Mayo Clinic collaboration has revived the healing wisdom ... extract described in a 17th century Dutch herbal text ... from the Atun tree effectively control bacteria that can ... circa 1650. He documented his traditional healing methods in ...
Cached Biology News:Jefferson researchers uncover new way nature turns genes on and off 2Stormy days ahead for coral reefs 2Stormy days ahead for coral reefs 3Mayo Clinic collaboration mining of ancient herbal text leads to potential new anti-bacterial drug 2
(Date:7/14/2014)... , July 14, 2014 Minerva Neurosciences (NASDAQ: ... of new therapies to treat neuropsychiatric diseases and disorders, ... been appointed vice president of finance and chief accounting ... is a senior executive with more than 20 years ... and life science companies. His background includes the management ...
(Date:7/14/2014)... (PRWEB) July 14, 2014 ... registry platform, announced that three PatientCrossroads-based patient ... the Phelan-McDermid Syndrome International Registry; and the ... been awarded contracts by the Patient-Centered Outcomes ... creation of a new health data network ...
(Date:7/13/2014)... (Brown University) -- The discovery 30 years ago of ... explosion of nanotechnology research. Now, there appears to be ... Brown University, Shanxi University and Tsinghua University in China ... forms a hollow molecular cage similar to a carbon ... cage structurepreviously only a matter of speculationdoes indeed exist. ...
(Date:7/13/2014)... 2014 Deep Research Report on Global ... in-depth study on the current state of the Nano ... provides a basic overview of the industry, including definitions, ... Chinese domestic market analysis are provided with a focus ... market. A comparison between the international and Chinese situation ...
Breaking Biology Technology:Minerva Neurosciences Announces Appointment Of Frederick W. Ahlholm As VP Of Finance And Chief Accounting Officer 2PatientCrossroads Fuels Development of New National Clinical Research Network 2PatientCrossroads Fuels Development of New National Clinical Research Network 3Researchers discover boron 'buckyball' 2Researchers discover boron 'buckyball' 32014 Nano Silver Industry in Global and China Regions Development Proposals Analysis Available at DeepResearchReports.com 22014 Nano Silver Industry in Global and China Regions Development Proposals Analysis Available at DeepResearchReports.com 3
... April 28 Sangamo,BioSciences, Inc. (Nasdaq: SGMO ... novel zinc finger DNA-binding proteins (ZFPs) for therapeutic ... Thomas G.,Wiggans to the company,s Board of Directors., ... Executive Officer of,Connetics Corporation, a biotechnology company, from ...
... ... product, ... Lucas has joined the Company as vice president,of sales and marketing. ... strategy, building the sales force, and leading the,commercial introduction of the ...
... CHINA, April 28 Simcere,Pharmaceutical Group (NYSE: ... generic pharmaceuticals and manufacturer of the patented,anti-cancer biotech ... has been,informed that one of its existing shareholders, ... beneficially owned by 15,individuals, including certain senior management ...
Cached Biology Technology:Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors 2Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors 3Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors 4AssureRx Adds VP of Sales and Marketing 2Simcere Pharmaceutical Group Reports Proposed Private Sale of Ordinary Shares by Existing Shareholder 2Simcere Pharmaceutical Group Reports Proposed Private Sale of Ordinary Shares by Existing Shareholder 3
Request Info...
Shake 'n' Stack oven - New Model (includes 10 bottle capacity rotisserie, adjustable feet, drip tray, manual)...
... Polymerase I from E. coli ... The enzyme also contains both ... 5'?3' exonuclease activity enables the ... gaps in the DNA as ...
... Stem Cell Expansion Kit - Monolayer Plus is ... NSC expansion as a monolayer in a serum-free ... Plus Media Supplement, which has been optimized for ... al . (1996) Genes & Development 10 ...
Biology Products: